EOS Imaging (Formerly Known as biospace med) Obtains Regulatory Authorization to Sell Its Products in Japan

PARIS--(BUSINESS WIRE)--EOS imaging (Paris:EOSI)(NYSE Euronext, FR0011191766-EOSI), the pioneer in orthopaedic 2D/3D imaging, today announced that Japanese regulatory authorities have authorized the sale of EOS® and sterEOS®. EOS imaging’s medical imaging system, which is comprised of EOS® and sterEOS®, offers very low radiation dose 2D and 3D X-ray imaging of the full body in a natural weight-bearing position (standing or sitting). It has already been approved for sale in more than 30 countries.

Help employers find you! Check out all the jobs and post your resume.